Proteasome inhibitors shorten replicative life span and induce a senescent‐like phenotype of human fibroblasts

The proteasome constitutes the main non‐lysosomal cellular protease activity, and plays a crucial role not only in the disposal of unwanted material, but also in the regulation of numerous cellular processes. Previously, we have reported that during the replicative senescence of WI‐38 fibroblasts there is a significant impairment in proteasome activity, which probably has important implications in the control of MAPK signaling and cellular proliferation. In this study, we report the potential role of the proteasome in the generation of the senescent phenotype in WI‐38 fibroblasts. Our results indicate that inhibition of proteasome activity leads to an impairment in cell proliferation, and a shortening of the life span. The results also indicate that inhibition of the proteasome in young cells induces a premature senescent‐like phenotype, as indicated by the increase in senescence‐associated β‐galactosidase (SA β‐gal) activity and the abundance of both p21 and collagenase mRNAs, as well as a decreased level of EPC‐1 mRNA known markers of cellular senescence, not previously shown to depend on proteasome activity. Together, our results suggest a molecular mechanism for the lack of responsiveness of human cells to growth factors, and point towards a role for the proteasome in the control of the life span of both cells and organisms. J. Cell. Physiol. © 2006 Wiley‐Liss, Inc.

[1]  L. Frisoni,et al.  Extension of replicative lifespan in WI-38 human fibroblasts by dexamethasone treatment is accompanied by suppression of p21 Waf1/Cip1/Sdi1 levels. , 2003, Experimental cell research.

[2]  R. G. Allen,et al.  Lack of Elk-1 phosphorylation and dysregulation of the extracellular regulated kinase signaling pathway in senescent human fibroblast. , 2001, Experimental cell research.

[3]  N. Chondrogianni,et al.  Overexpression of Proteasome β5 Assembled Subunit Increases the Amount of Proteasome and Confers Ameliorated Response to Oxidative Stress and Higher Survival Rates*[boxs] , 2005, Journal of Biological Chemistry.

[4]  A. Bruce-Keller,et al.  Analysis of gene expression in neural cells subject to chronic proteasome inhibition. , 2004, Free radical biology & medicine.

[5]  C. Franceschi,et al.  Fibroblast cultures from healthy centenarians have an active proteasome , 2000, Experimental Gerontology.

[6]  J. R. Smith,et al.  Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.

[7]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[8]  J. Broers,et al.  Detailed analysis of cell cycle kinetics upon proteasome inhibition. , 1997, Cytometry.

[9]  M. Muratani,et al.  How the ubiquitin–proteasome system controls transcription , 2003, Nature Reviews Molecular Cell Biology.

[10]  P. Cresswell,et al.  Processing and delivery of peptides presented by MHC class I molecules. , 1996, Current opinion in immunology.

[11]  A. Lorenzini,et al.  Regulation of Collagenase Expression during Replicative Senescence in Human Fibroblasts by Akt-Forkhead Signaling* , 2002, The Journal of Biological Chemistry.

[12]  E. Becker,et al.  Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d. , 1989, Biochemical and biophysical research communications.

[13]  Bai-Lin Wu,et al.  High Intensity ras Signaling Induces Premature Senescence by Activating p38 Pathway in Primary Human Fibroblasts* , 2004, Journal of Biological Chemistry.

[14]  D. Wolf,et al.  Proteasomes: destruction as a programme. , 1996, Trends in biochemical sciences.

[15]  A. Di Leonardo,et al.  Differential gene expression in p53-mediated G(1) arrest of human fibroblasts after gamma-irradiation or N-phosphoacetyl-L-aspartate treatment. , 2000, Carcinogenesis.

[16]  O. Sezer,et al.  Proteasome: an emerging target for cancer therapy , 2005, Anti-cancer drugs.

[17]  W. Markesbery,et al.  Possible involvement of proteasome inhibition in aging: implications for oxidative stress , 2000, Mechanisms of Ageing and Development.

[18]  T. Hunter,et al.  The PHD domain of MEKK1 acts as an E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2. , 2002, Molecular cell.

[19]  J. Tschopp,et al.  Granzymes, a Family of Serine Proteases Released from Granules of Cytolytic T Lymphocytes upon T Cell Receptor Stimulation , 1988, Immunological reviews.

[20]  R. G. Allen,et al.  Is beta-galactosidase staining a marker of senescence in vitro and in vivo? , 2000, Experimental cell research.

[21]  Jeffrey N Keller,et al.  Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.

[22]  A. J. Millis,et al.  Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. , 1992, Experimental cell research.

[23]  Goberdhan P Dimri,et al.  The helix-loop-helix protein Id-1 and a retinoblastoma protein binding mutant of SV40 T antigen synergize to reactivate DNA synthesis in senescent human fibroblasts. , 1996, Developmental genetics.

[24]  T. Zglinicki,et al.  Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. , 2000, Free radical biology & medicine.

[25]  J. Louie,et al.  Proteasome function and protein oxidation in the aged retina. , 2002, Experimental eye research.

[26]  K. Scharffetter-Kochanek,et al.  Psoralen plus UVA (PUVA) induced premature senescence as a model for stress-induced premature senescence , 2002, Experimental Gerontology.

[27]  B. Friguet,et al.  Age-related alterations of proteasome structure and function in aging epidermis , 2000, Experimental Gerontology.

[28]  A. Goldberg,et al.  A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. , 1986, The Journal of biological chemistry.

[29]  J. Keller,et al.  Proteasome synthesis and assembly are required for survival during stationary phase. , 2004, Free radical biology & medicine.

[30]  C. Volker,et al.  Age-dependent modifications of gene expression in human fibroblasts. , 1998, Critical reviews in eukaryotic gene expression.

[31]  J. R. Smith,et al.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.

[32]  M. Pagano,et al.  Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation , 2003, Cell.

[33]  Marc W. Kirschner,et al.  How Proteolysis Drives the Cell Cycle , 1996, Science.

[34]  D. Ferrington,et al.  Altered proteasome structure, function, and oxidation in aged muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  D. Ferrington,et al.  Altered proteasome function and subunit composition in aged muscle. , 2004, Archives of biochemistry and biophysics.

[36]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[37]  M. Tresini,et al.  Regulation of EPC‐1/PEDF in normal human fibroblasts is posttranscriptional , 2000, Journal of cellular biochemistry.

[38]  B. Friguet,et al.  Age-dependent declines in proteasome activity in the heart. , 2002, Archives of biochemistry and biophysics.

[39]  N. Chondrogianni,et al.  Proteasome inhibition induces a senescence-like phenotype in primary human fibroblasts cultures , 2004, Biogerontology.

[40]  V. Cristofalo,et al.  A standard procedure for cultivating human diploid fibroblastlike cells to study cellular aging , 1980 .

[41]  S. Meloche,et al.  Rapid Turnover of Extracellular Signal-Regulated Kinase 3 by the Ubiquitin-Proteasome Pathway Defines a Novel Paradigm of Mitogen-Activated Protein Kinase Regulation during Cellular Differentiation , 2003, Molecular and Cellular Biology.

[42]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  W. Markesbery,et al.  Proteasome inhibition induces reversible impairments in protein synthesis , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  R. Pignolo,et al.  Senescent WI-38 cells fail to express EPC-1, a gene induced in young cells upon entry into the G0 state. , 1993, The Journal of biological chemistry.

[45]  U. Ponnappan.  Ubiquitin–proteasome pathway is compromised in CD45RO+ and CD45RA+ T lymphocyte subsets during aging , 2002, Experimental Gerontology.

[46]  J. Ross,et al.  Control of messenger RNA stability in higher eukaryotes. , 1996, Trends in genetics : TIG.

[47]  R. Pignolo,et al.  Analysis of EPC‐1 growth state–dependent expression, specificity, and conservation of related sequences , 1995, Journal of cellular physiology.

[48]  V. Cristofalo,et al.  Loss of EPC-1/PEDF expression during skin aging in vivo. , 2004, The Journal of investigative dermatology.

[49]  B. Friguet,et al.  Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.

[50]  M. Tresini,et al.  A phosphatidylinositol 3-kinase inhibitor induces a senescent-like growth arrest in human diploid fibroblasts. , 1998, Cancer research.

[51]  J. Remacle,et al.  Cell cycle regulation in H2O2-induced premature senescence of human diploid fibroblasts and regulatory control exerted by the papilloma virusE6 and E7 proteins , 2000, Experimental Gerontology.

[52]  V. Cristofalo,et al.  Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. , 1973, Experimental cell research.

[53]  H. J. Phillips.  Dye Exclusion Tests for Cell Viability , 1973 .

[54]  S. Wilk,et al.  An inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces arrest in G2-phase and metaphase in HeLa cells. , 1996, European journal of cell biology.

[55]  M. Tresini,et al.  Metabolic stabilization of MAP kinase phosphatase-2 in senescence of human fibroblasts. , 2003, Experimental cell research.

[56]  Howard Hughes.  Lactacystin, Proteasome Function, and Cell Fate* , 1998, The Journal of Biological Chemistry.

[57]  S. Hoffmann,et al.  Role and Function of the 26S Proteasome in Proliferation and Apoptosis , 2002, Laboratory Investigation.

[58]  B. Friguet,et al.  Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  A. Sheerin,et al.  Altered composition and DNA binding activity of the AP-1 transcription factor during the ageing of human fibroblasts , 2001, Mechanisms of Ageing and Development.

[60]  R. Huber,et al.  Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. , 2004, Biochimica et biophysica acta.

[61]  Yong Wang,et al.  Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. , 2004, Experimental cell research.

[62]  T. Reinheckel,et al.  Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  M. Hochstrasser.  Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. , 1995, Current opinion in cell biology.

[64]  C. Crews,et al.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Campisi,et al.  Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. , 1990, Science.